ADIM
HP icon

Alpha DNA Investment Management’s Helmerich & Payne HP Stock Holding History

Alpha DNA Investment Management’s Portfolio HP Stock Details HP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,771
Closed -$1.08M – 174
2022
Q4 		$1.08M Buy
+21,771
New +$1.04M 0.38% 88
2022
Q3 		– Sell
-22,027
Closed -$947K – 172
2022
Q2 		$947K Buy
+22,027
New +$1.02M 0.81% 77

Other funds holding HP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alpha DNA Investment Management's HP Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Helmerich & Payne (HP) in Q1 2023, closing a stake of 21,771 shares — an estimated $1.08M sold.

Alpha DNA Investment Management first reported a position in HP in Q2 2022 and held it in 2 quarters. The position peaked at $1.08M in Q4 2022. 378 funds tracked by Wall St. Rank hold HP as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining Helmerich & Payne position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 21,771 Helmerich & Payne shares in Q1 2023, an estimated $1.08M.
  • Alpha DNA Investment Management first reported a position in Helmerich & Payne in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Helmerich & Payne position peaked at $1.08M in Q4 2022.
  • 378 funds tracked by Wall St. Rank held Helmerich & Payne as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.